Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Lymphoma and STK11[original query] |
---|
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Jan . Hwang David H, Sholl Lynette M, Rojas-Rudilla Vanesa, Hall Dimity L, Shivdasani Priyanka, Garcia Elizabeth P, MacConaill Laura E, Vivero Marina, Hornick Jason L, Kuo Frank C, Lindeman Neal I, Dong F |
[Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 Apr 23 (4): 239-246. Liang Yu, Hou Helei, Jiang Man, Zhang Chuantao, Liu Dong, Zhang Xiaoch |
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: